Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Biosensors Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Biosensors Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Biosensors Market: Technology Estimates & Trend Analysis

4.1. Technology Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Biosensors Market by Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Thermal
4.4.1.1. Market estimates and forecasts 2023 to 2032 (USD Million)
4.4.2. Electrochemical
4.4.2.1. Market estimates and forecasts 2023 to 2032 (USD Million)
4.4.3. Piezoelectric
4.4.3.1. Market estimates and forecasts 2023 to 2032 (USD Million)
4.4.4. Optical
4.4.4.1. Market estimates and forecasts 2023 to 2032 (USD Million)

Chapter 5. Biosensors Market: Application Estimates & Trend Analysis

5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Biosensors Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Medical
5.4.1.1. Market estimates and forecasts 2023 to 2032 (USD Million)
5.4.2. Cholesterol
5.4.2.1. Market estimates and forecasts 2023 to 2032 (USD Million)
5.4.3. Blood Glucose
5.4.3.1. Market estimates and forecasts 2023 to 2032 (USD Million)
5.4.4. Blood Gas Analyzer
5.4.4.1. Market estimates and forecasts 2023 to 2032 (USD Million)
5.4.5. Pregnancy Testing
5.4.5.1. Market estimates and forecasts 2023 to 2032 (USD Million)
5.4.6. Drug Discovery
5.4.6.1. Market estimates and forecasts 2023 to 2032 (USD Million)
5.4.7. Infectious Disease
5.4.7.1. Market estimates and forecasts 2023 to 2032 (USD Million)
5.4.8. Food Toxicity
5.4.8.1. Market estimates and forecasts 2023 to 2032 (USD Million)
5.4.9. Bioreactor
5.4.9.1. Market estimates and forecasts 2023 to 2032 (USD Million)
5.4.10. Agriculture
5.4.10.1. Market estimates and forecasts 2023 to 2032 (USD Million)
5.4.11. Environment
5.4.11.1. Market estimates and forecasts 2023 to 2032 (USD Million)
5.4.12. Others
5.4.12.1. Market estimates and forecasts 2023 to 2032 (USD Million)

Chapter 6. Biosensors Market: End-use Estimates & Trend Analysis

6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Biosensors Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Home Healthcare Diagnostics
6.4.1.1. Market estimates and forecasts 2023 to 2032 (USD Million)
6.4.2. POC Testing
6.4.2.1. Market estimates and forecasts 2023 to 2032 (USD Million)
6.4.3. Food Industry
6.4.3.1. Market estimates and forecasts 2023 to 2032 (USD Million)
6.4.4. Research Laboratories
6.4.4.1. Market estimates and forecasts 2023 to 2032 (USD Million)
6.4.5. Security and Bio-Defense
6.4.5.1. Market estimates and forecasts 2023 to 2032 (USD Million)

Chapter 7. Biosensors Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2023 to 2032 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2023 to 2032 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2023 to 2032 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2023 to 2032 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2023 to 2032 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2023 to 2032 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2023 to 2032 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2023 to 2032 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2023 to 2032 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2023 to 2032 (USD Million)
7.6.9. Netherlands
7.6.9.1. Key country dynamics
7.6.9.2. Regulatory framework/ reimbursement structure
7.6.9.3. Competitive scenario
7.6.9.4. Netherlands market estimates and forecasts 2023 to 2032 (USD Million)
7.6.10. Belgium
7.6.10.1. Key country dynamics
7.6.10.2. Regulatory framework/ reimbursement structure
7.6.10.3. Competitive scenario
7.6.10.4. Belgium market estimates and forecasts 2023 to 2032 (USD Million)
7.6.11. Switzerland
7.6.11.1. Key country dynamics
7.6.11.2. Regulatory framework/ reimbursement structure
7.6.11.3. Competitive scenario
7.6.11.4. Switzerland market estimates and forecasts 2023 to 2032 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2023 to 2032 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2023 to 2032 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2023 to 2032 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2023 to 2032 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2023 to 2032 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/ reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2023 to 2032 (USD Million)
7.7.7. Indonesia
7.7.7.1. Key country dynamics
7.7.7.2. Regulatory framework/ reimbursement structure
7.7.7.3. Competitive scenario
7.7.7.4. Indonesia market estimates and forecasts 2023 to 2032 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2023 to 2032 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Mexico market estimates and forecasts 2023 to 2032 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts 2023 to 2032 (USD Million)
7.8.4. Colombia
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework/ reimbursement structure
7.8.4.3. Competitive scenario
7.8.4.4. Colombia market estimates and forecasts 2023 to 2032 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2023 to 2032 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/ reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2023 to 2032 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/ reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2023 to 2032 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/ reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2023 to 2032 (USD Million)
7.9.5. Turkey
7.9.5.1. Key country dynamics
7.9.5.2. Regulatory framework/ reimbursement structure
7.9.5.3. Competitive scenario
7.9.5.4. Turkey market estimates and forecasts 2023 to 2032 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.4. Company Profiles
8.4.1. BIO-RAD LABORATORIES INC.
8.4.1.1. Company overview
8.4.1.2. Financial Performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. MEDTRONIC
8.4.2.1. Company overview
8.4.2.2. Financial Performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. ABBOTT LABORATORIES
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Product benchmarking
8.4.4. BIOSENSORS INTERNATIONAL GROUP, LTD.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. PINNACLE TECHNOLOGIES INC.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. ERCON, INC.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. DUPONT BIOSENSOR MATERIALS
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. JOHNSON & JOHNSON
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. KONINKLIJKE PHILIPS N.V.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. LIFESCAN, INC.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. QTL BIODETECTION LLC.
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. MOLECULAR DEVICES CORPORATION
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. NOVA BIOMEDICAL
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
8.4.14. MOLEX LLC
8.4.14.1. Company overview
8.4.14.2. Financial performance
8.4.14.3. Product benchmarking
8.4.14.4. Strategic initiatives
8.4.15. TDK CORPORATION
8.4.15.1. Company overview
8.4.15.2. Financial performance
8.4.15.3. Product benchmarking
8.4.15.4. Strategic initiatives
8.4.16. ZIMMER & PEACOCK AS
8.4.16.1. Company overview
8.4.16.2. Financial performance
8.4.16.3. Product benchmarking
8.4.16.4. Strategic initiatives
8.4.17. SIEMENS HEALTHCARE
8.4.17.1. Company overview
8.4.17.2. Financial performance
8.4.17.3. Product benchmarking
8.4.17.4. Strategic initiatives